bi-specific IgG-based targeted therapeutics (Merck Serono)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebi-specific IgG-based targeted therapeutics (Merck Serono)

Drug Alias NameIgG-based targeted therapeutics (Merck Serono)mAb2 therapeutics (Merck Serono)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Serono Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Serono Sa

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A